Need something to read this weekend? The entire March issue of Psychiatric Times is now live on our website! In this month's issue, you can explore... ?? The Special Report on cognition ?? A CME article on post-acute sequelae of COVID-19 ?? Our cover story on resilience in the wake of disaster Read it here: https://lnkd.in/gceNEp94
关于我们
Psychiatric Times provides timely clinical, commentary, and practical cutting-edge content.. As the voice of psychiatry, Psychiatric Times’ premiere online and print content is written by and for mental health care physicians and professionals.
- 网站
-
https://www.psychiatrictimes.com/
Psychiatric Times的外部链接
- 所属行业
- 媒体制作
- 规模
- 501-1,000 人
- 总部
- Cranbury，NJ
- 类型
- 私人持股
- 领域
- mental health、psychiatry、health和medicine
地点
-
主要
获取路线
2 Clarke Drive
Suite 100
US，NJ，Cranbury，08512
Psychiatric Times员工
-
Heidi Anne Duerr
-
John J. Miller, M.D.
Editor in Chief at Psychiatric Times
-
Dr. Wilsa Charles Malveaux, M.D., M.A., F.A.P.A.
Through specializing in sports psychiatry and high-performance mental health care, I help those I work with to navigate roadblocks, build mental…
-
Chris Aiken, MD
Director, Psych Partners. Editor-in-Chief, Carlat Report
动态
-
Have you heard of cinematherapy? There is a new program centered on addiction in film that is now used in recovery centers and clinics across the US and Canada. Learn more here: https://lnkd.in/gBYbVCNY
-
Gain expert insights from this informative video series on adjunctive treatment of major depressive disorder using atypical antipsychotics. #ad Watch here: https://hubs.li/Q03dNw_20
-
-
Alzamend announced its plans to initiate a highly anticipated phase 2 clinical study of AL001, a novel lithium-delivery system for the treatment of patients with major depressive disorder, in late 2025. https://lnkd.in/ghSS4hJU
-
Based on a new study, ketamine may be preferred among outpatients and for those with “moderately severe or severe” depression, whereas ECT may be preferred among inpatients and those with “very severe” depression. https://lnkd.in/gfYZVWAa
-
In a?large joint statement, leading psychiatric organizations addressed Executive Order 14212, which called for an assessment of the risks associated with psychotropic medications, including selective serotonin reuptake inhibitors (SSRIs), antipsychotics, mood stabilizers, and stimulants. The statement pushed back against concerns that could lead to misinformation and reduced access to evidence-based treatments.?
此处无法显示此内容
在领英 APP 中访问此内容等
-
Axsome Therapeutics, Inc. today announced that the FOCUS phase 3 trial of solriamfetol for the treatment of ADHD achieved its primary and key secondary endpoints, demonstrating statistically significant improvements in ADHD symptoms and disease severity compared with placebo. https://lnkd.in/gbspeUq5
-
Premenstrual dysphoric disorder is a severe and debilitating form of premenstrual syndrome that affects women between ovulation and the start of menstruation. https://lnkd.in/gWa2binT
-
-
March is Brain Injury Awareness Month ?? Learn more about how we can address challenges that arise in treating individuals with acquired brain injury. https://lnkd.in/gPwhHsms
-
Joint statements from leading psychiatric organizations voice concern about impact on patient care from executive orders and budget cuts. https://lnkd.in/gtsAAiBg